Regentis Biomaterials Ltd. (RGNT) Stock Price

RGNTStock

$2.00

Market Cap$14.05M

P/E—

PEG Ratio—

Div yield—

Beta—

RGNT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-61.93%

Price vs S&P 500 (4W)5.41%

VGM Score37.07

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
RGNTRegentis Biomaterials Ltd.	—	—	D	$2.00
ISRGIntuitive Surgical Inc.	D	B	C	$372.60
EWEdwards Lifesciences Corp	D	C	B	$90.21
STESTERIS plc	C	B	C	$233.78
ZBHZimmer Biomet Holdings, Inc.	B	C	B	$100.91
SNNSmith & Nephew plc	B	C	C	$28.97
ALGNAlign Technology Inc	B	D	C	$157.58
MSAMine Safety Incorporated	C	C	B	$190.34
ESTAEstablishment Labs Holdings Inc.	F	A	C	$70.64
ENOVEnovis Corporation	B	D	C	$24.90
CDRECadre Holdings, Inc.	C	C	C	$30.74
AVNSAvanos Medical, Inc.	B	D	C	$24.99
AVRAnteris Technologies Global Corp. Common Stock	F	D	B	$8.74
SMTISanara MedTech Inc. Common Stock	D	C	B	$34.57
CNXUConexeu Sciences Inc. Common Stock	—	—	F	$7.07
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	B	D	D	$2.34
INGNInogen Inc	B	D	C	$5.50
LAKELakeland Industries Inc	B	D	B	$11.86
SPAISafe Pro Group Inc. Common Stock	F	C	D	$4.63
MYOMyomo Inc.	C	B	A	$1.60
APTAlpha Pro Tech, Ltd.	A	D	C	$5.35
NTRBNutriband Inc. Common Stock	F	D	C	$4.46
COCHEnvoy Medical, Inc. Class A Common Stock	D	D	D	$0.69
MLSSMilestone Scientific, Inc. Common Stock	D	D	B	$0.50
LFWDLifeward Ltd. Ordinary Shares	B	D	B	$7.46
HSCSHeartSciences Inc. Common Stock	F	F	B	$3.03
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	C	$3.01
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	C	F	D	$0.36
FEEDENvue Medical, Inc. Common Stock	A	F	F	$0.34
BBLGBone Biologics Corp Common Stock	—	—	D	$0.61
BBLGWBone Biologics Corp Warrants	—	—	F	$5.70
COCHWEnvoy Medical, Inc Warrant	—	—	C	$0.04
HSCSWHeartSciences Inc. Warrant	—	—	D	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	$0.45

About Regentis Biomaterials Ltd.

Regentis Biomaterials develops regenerative medicine solutions for orthopedic tissue repair. Its lead product, GelrinC, is a cell-free hydrogel implant designed to treat cartilage injuries in the knee, based on the company's proprietary Gelrin platform. The company targets the significant market opportunity in orthopedic regenerative medicine.